Holmusk Expands NeuroBlu to 46 Million Patients, Adding Depth and Biomarker Data Across Neurology and Behavioral Health
Holmusk has expanded its NeuroBlu platform to include over 46 million de-identified patient records, incorporating new data from top-tier neurological health systems. The update focuses on integrating longitudinal EHR data with structured biomarker and outcomes measures to improve research-grade signals for neurological and behavioral health.
Why it matters
This expansion provides researchers with a massive, high-quality dataset that could accelerate the development of treatments for complex neurological and mental health conditions.
Holmusk Expands NeuroBlu to 46 Million Patients, Adding Depth and Biomarker Data Across Neurology and Behavioral Health
The article is a straightforward report based on a corporate press release, using neutral, descriptive language.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in